Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort vs Budesonide in Children with Asthma (SPROUT)
NCT00646321Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2003
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of budesonide and formoterol in asthma (2 arms), sponsored by AstraZeneca. Primary endpoint: Change in evening Peak Expiratory Flow at 12 weeks. Started Apr 2003; status: completed.
02
Drugs
budesonideformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00646321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00646321.